| 000 | 02725 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250516002622.0 | ||
| 264 | 0 | _c20101215 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/CIRCRESAHA.110.229054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuo, Danny | |
| 245 | 0 | 0 |
_aLoss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress. _h[electronic resource] |
| 260 |
_bCirculation research _cNov 2010 |
||
| 300 |
_a1275-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 | _aBiomechanical Phenomena |
| 650 | 0 | 4 |
_aCadherins _xmetabolism |
| 650 | 0 | 4 |
_aCardiomegaly _xdrug therapy |
| 650 | 0 | 4 | _aCell Adhesion |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aClass Ib Phosphatidylinositol 3-Kinase _xdeficiency |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aExtracellular Matrix _xmetabolism |
| 650 | 0 | 4 |
_aFibroblasts _xenzymology |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aHeart Failure _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 13 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 14 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 |
_aMechanotransduction, Cellular _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMyocardial Contraction |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xenzymology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aStress, Mechanical |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 650 | 0 | 4 |
_abeta Catenin _xmetabolism |
| 700 | 1 | _aKassiri, Zamaneh | |
| 700 | 1 | _aBasu, Ratnadeep | |
| 700 | 1 | _aChow, Fung L | |
| 700 | 1 | _aKandalam, Vijay | |
| 700 | 1 | _aDamilano, Federico | |
| 700 | 1 | _aLiang, Wenbin | |
| 700 | 1 | _aIzumo, Seigo | |
| 700 | 1 | _aHirsch, Emilio | |
| 700 | 1 | _aPenninger, Josef M | |
| 700 | 1 | _aBackx, Peter H | |
| 700 | 1 | _aOudit, Gavin Y | |
| 773 | 0 |
_tCirculation research _gvol. 107 _gno. 10 _gp. 1275-89 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCRESAHA.110.229054 _zAvailable from publisher's website |
| 999 |
_c20177803 _d20177803 |
||